Ziccum AB (publ) has received notification from CEPI (the Coalition for Epidemic Preparedness), that its joint Expression of Interest, submitted in partnership with an mRNA-focused biotech company in January 2023, has not been selected for the next stage of application work. In its notification, CEPI points Ziccum towards an upcoming 2023 Call for Proposals for Applications on vaccine manufacturing innovation including that it may be a good fit with technology and an opportunity for to collaborate with CEPI in the future". After initially communicating that it would not submit a proposal, Ziccum did submit a first stage brief application, a so called Expression of Interest, to CEPI with a Biotech partner in January 2023, before the company's recent announcement of a fully funded mRNA Feasibility Study with an international Biotech leader in mRNA development.